Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tahereh Soltantoyeh"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionChimeric antigen receptor (CAR) T cell therapy has transformed the treatment of hematological malignancies. However, its efficacy in solid tumors is limited by the immunosuppressive tumor microenvironment that compromises CAR T cell antit
Externí odkaz:
https://doaj.org/article/ccb122380320458c812a0254c4100a1e
Autor:
Ahmad Reza Panahi Meymandi, Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Mina Hosseini, Jamshid Hadjati, Hamid Reza Mirzaei
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionChimeric Antigen Receptor (CAR) T cell therapy has demonstrated remarkable success in treating hematological malignancies. However, its efficacy against solid tumors, including cervical cancer, remains a challenge. Hypoxia, a common featu
Externí odkaz:
https://doaj.org/article/c6420e9ccf5b471fbf5a87c865e61c36
Autor:
Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Fariba Yarandi, Jamshid Hadjati, Hamid Reza Mirzaei
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Chemotherapy and surgery have been the mainstays of epithelial ovarian cancer (EOC) treatment so far. Cellular immunotherapies such as CAR T cell therapy have recently given hope of a cure for solid tumors like EOC. However, extri
Externí odkaz:
https://doaj.org/article/16bd776dc0e84f6482ed5339e686af93
Autor:
Ahmad Reza Panahi Meymandi, Behnia Akbari, Tahereh Soltantoyeh, Jamshid Hadjati, Daniel J. Klionsky, Behnam Badie, Hamid Reza Mirzaei
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Despite chimeric antigen receptor (CAR) T cell therapy’s extraordinary success in subsets of B-cell lymphoma and leukemia, various barriers restrict its application in solid tumors. This has prompted investigating new approaches for producing CAR T
Externí odkaz:
https://doaj.org/article/b64d395a31224241a28c776b9b3d16e6
Autor:
Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Farhad Jadidi-Niaragh, Jamshid Hadjati, Christine E. Brown, Hamid Reza Mirzaei
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionFor many years, surgery, adjuvant and combination chemotherapy have been the cornerstone of pancreatic cancer treatment. Although these approaches have improved patient survival, relapse remains a common occurrence, necessitating the expl
Externí odkaz:
https://doaj.org/article/8c233636201a4afbb5f9b6604d6b1ab3
Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors
Autor:
Navid Ghahri-Saremi, Behnia Akbari, Tahereh Soltantoyeh, Jamshid Hadjati, Saba Ghassemi, Hamid Reza Mirzaei
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Chimeric antigen receptor (CAR) T cell therapy has shown unprecedented success in treating advanced hematological malignancies. Its effectiveness in solid tumors has been limited due to heterogeneous antigen expression, a suppressive tumor microenvir
Externí odkaz:
https://doaj.org/article/dd5882a477c849f89a7ef60210ead2f6
Autor:
Mohammad Mehdi Amiri, Tannaz Bahadori, Tahereh Soltantoyeh, Reza Hosseini-Ghatar, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani, Fazel Shokri
Publikováno v:
Iranian Journal of Immunology, Vol 16, Iss 1, Pp 26-42 (2019)
Externí odkaz:
https://doaj.org/article/fd15e368307246e6836d2c63819f866f
Autor:
Reza Hosseini-Ghatar, Tahereh Soltantoyeh, Motahareh Bahadori, Jalal Khoshnoodi, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri, Fazel Shokri
Publikováno v:
Iranian Journal of Immunology, Vol 14, Iss 3, Pp 200-214 (2017)
Background: Human epidermal growth factor receptor 2 (HER2) has a crucial role in several malignancies. The extracellular domain of HER2 (HER2-ECD) has been extensively employed as an important target in passive and active immunotherapy. Isolated rec
Externí odkaz:
https://doaj.org/article/c783a2377168488b9d26cfec36d82d54
Autor:
Tahereh Soltantoyeh, Behnia Akbari, Amirali Karimi, Ghanbar Mahmoodi Chalbatani, Navid Ghahri-Saremi, Jamshid Hadjati, Michael R. Hamblin, Hamid Reza Mirzaei
Publikováno v:
Cells, Vol 10, Iss 6, p 1450 (2021)
Metastatic melanoma is the most aggressive and difficult to treat type of skin cancer, with a survival rate of less than 10%. Metastatic melanoma has conventionally been considered very difficult to treat; however, recent progress in understanding th
Externí odkaz:
https://doaj.org/article/e5dbf7f728794392b466c21586b89b7c
Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors
Autor:
Jamshid Hadjati, Navid Ghahri-Saremi, Tahereh Soltantoyeh, Hamid Reza Mirzaei, Behnia Akbari, Saba Ghassemi
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Chimeric antigen receptor (CAR) T cell therapy has shown unprecedented success in treating advanced hematological malignancies. Its effectiveness in solid tumors has been limited due to heterogeneous antigen expression, a suppressive tumor microenvir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c81faba622f67599882bcac78490e379
http://europepmc.org/articles/PMC8552010
http://europepmc.org/articles/PMC8552010